Message Font: Serif | Sans-Serif
No. of Recommendations: 7
I couldn't help but notice that Regeneron recently received FDA approval of Arcalyst (rilonacept) for CAPS. Good to see there are people working on this.

Note: Cryopyrin-Associated Periodic Syndromes (CAPS), a group of rare, inherited, auto-inflammatory conditions characterized by life-long symptoms of rash, fever/chills, joint pain, eye redness/pain, and fatigue; and Motley Fool CAPS are not necessarily indications that should be treated similarly.

Nevertheless, here is a quote from the press release.

"Recognizing the painful, isolated lives experienced by patients with CAPS, we are pleased that we can offer these patients an FDA-approved therapy that helps control its debilitating symptoms," said Leonard S. Schleifer, M.D., Ph.D., Regeneron's president and chief executive officer.

Zz - just saying
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.